The global bioimpedance devices market is projected to grow from USD 694.1 million in 2025 to approximately USD 1,369.7 million by 2035. This reflects a compound annual growth rate (CAGR) of 6.7% over the forecast period. In 2024, demand for bioimpedance devices remained steady across nephrology, oncology, cardiology, and nutrition-based specialties. By 2025, adoption has …
Continue reading “Bioimpedance Devices Market Forecast USD 1,369.7 Million by 2035”